Novavax Inc. sell Bank of America Co.
Start price
20.08.25
/
50%
€7.64
Target price
20.08.26
€6.02
Performance (%)
-26.65%
Price
12.12.25
€5.60
Summary
This prediction is currently active. The price of Novavax Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -26.65%. This prediction currently runs until 20.08.26. The prediction end date can be changed by Bank_of_America_Co_ at any time. Bank_of_America_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Novavax Inc. | -5.548% | -5.548% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
Comments by Bank_of_America_Co_ for this prediction
In the thread Novavax Inc. diskutieren
Novavax (NASDAQ:NVAX) had its "underperform" rating reaffirmed by analysts at Bank of America Corporation. They now have a $7.00 price target on the stock.
Ratings data for NVAX provided by MarketBeat